<!DOCTYPE html>
<html lang="en">
<head>
    <title>Hao Li CV</title>
    
    <!-- Meta -->
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Responsive HTML5 Resume/CV Template for Developers">
    <meta name="author" content="Xiaoying Riley at 3rd Wave Media">    
    <link rel="shortcut icon" href="favicon.ico">  
    <!-- Google Font -->
    <link href='https://fonts.googleapis.com/css?family=Roboto:400,500,400italic,300italic,300,500italic,700,700italic,900,900italic' rel='stylesheet' type='text/css'>
    <!-- FontAwesome JS-->
	<script defer src="https://rgnyygmx.github.io/assets/fontawesome/js/all.min.js"></script>
    <!-- Global CSS -->
    <link rel="stylesheet" href="https://rgnyygmx.github.io/assets/plugins/bootstrap/css/bootstrap.min.css">   
    <!-- Theme CSS -->  
    <link id="theme-style" rel="stylesheet" href="https://rgnyygmx.github.io/assets/css/orbit-1.css">
    
    <!-- DEMO ONLY --> 
    <link id="theme-style" rel="stylesheet" href="https://rgnyygmx.github.io/demo/demo.css">
    <style>
        p{
            font-size: 18px;
		margin-bottom:0!important;
		
    font-family: Roboto;
		 }
.sidebar-wrapper .interests-list li {
    margin-bottom: 10px;
    font-size: 18px;
}
       
	.main-wrapper .job-title {
    color: #3F4650;
    font-size: 22px;
    margin-top: 0;
    margin-bottom: 0;
    font-weight: 500;
    margin-top: 15px;
		text-transform: uppercase;
    font-family: Roboto;
}    
	    
	    
	    .sidebar-wrapper a {
    color: #fff;
    font-size: 18px;
}
    </style>
</head> 

<body>
	
	<!-- DEMO ONLY --> 
	<!-- <div class="demo-banner py-3 text-white text-center font-weight-bold">Need a comprehensive portfolio template for your personal site? <a class="btn demo-btn-on-bg text-white font-weight-bold ml-2" href="https://themes.3rdwavemedia.com/bootstrap-templates/resume/instance-bootstrap-portfolio-theme-for-developers/" target="_blank"><i class="fas fa-external-link-alt mr-2"></i>Check out this Bootstrap 4 theme</a>
	</div> -->
	
    <div class="wrapper">
        <div class="sidebar-wrapper">
            <div class="profile-container">
                <img class="profile" src="re.jpg" alt="" />
                <h1 class="name">Hao Li</h1>
                <h1 class="name">M.Med</h1>
            </div><!--//profile-container-->
        

            <div class="languages-container container-block">
                <!-- <h2 class="container-block-title">Languages</h2> -->
                <ul class="list-unstyled interests-list">
                    <li>Date of birth <span class="lang-">:04/25/1996</span></li>
                    <li>Nationality <span class="lang-">:China</span></li>
			<li>Gender <span class="lang-">:Male</span></li>
                    <li>ORCID <a title="https://orcid.org/0000-0002-9377-1706" href="https://orcid.org/0000-0002-9377-1706">:0000-0002-9377-1706</a></li>
                    <li>Research Gate Score <a title="https://www.researchgate.net/profile/Hao_Li103" href="https://www.researchgate.net/profile/Hao_Li103">:23.26</a></li>
                    <li>Highlight <span class="lang-">:Medical Data Mining</span></li>
                    <li>Number of First-author SCI papers <span class="lang-">:Seven</span></li>
                </ul>
            </div>
            
            <div class="contact-container container-block">
                <ul class="list-unstyled contact-list">
                    <li class="email"><i class="fas fa-envelope"></i><a href="mailto: lrgnyygmx@163.com">lrgnyygmx@163.com</a></li>
                    <li class="phone"><i class="fas fa-phone"></i><a href="tel:+86 15736540030">+86 15736540030</a></li>
                    <li class="website"><i class="fas fa-map"></i>
                    <p>Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, No.1
                    You Yi Rd. Chongqing 400016, China.</p>
                    
                    </li>
                  
                </ul>
            </div>
            <!--//contact-container-->
          
            
          
         
            
        </div><!--//sidebar-wrapper-->
        
        <div class="main-wrapper">
            
            <section class="section summary-section">
                <h2 class="section-title"><span class="icon-holder"><i class="fas fa-user"></i></span>RESEARCH OBJECTIVES</h2>
                <div class="summary">
                <p> <strong>•</strong> Basic and clinical researches of breast and thyroid diseases</p>
                <p> • Cancer epidemiology and screening strategy</p>
                <p> • Hepatitis B virus related extrahepatic cancers</p>
                <p> • Vitamin D supplementation and bone health</p>
                <p> • Clinical research of COVID-19</p>
                <p> • Medical science popularization</p>

                </div><!--//summary-->
            </section><!--//section-->




           
            
            <section class="section experiences-section">
                <h2 class="section-title"><span class="icon-holder"><i class="fas fa-briefcase"></i></span>EDUCATION AND HONORS</h2>
                
                <div class="item">
                    <div class="meta">
                        <div class="upper-row">
                            <h3 class="job-title">Senior high school</h3>
                            <div class="time">Sept. 2010-June. 2013</div>
                        </div><!--//upper-row-->
                        <div class="company"></div>
                    </div><!--//meta-->
                    <div class="details">

                    <p>• Senior high school student, Fuling Experimental high school, Chongqing, China</p>

                    </div><!--//details-->
                </div><!--//item-->


                <div class="item">
                    <div class="meta">
                        <div class="upper-row">
                            <h3 class="job-title">B. Med</h3>
                            <div class="time">Sept. 2013-June. 2018</div>
                        </div>
                        <!--//upper-row-->
                        <div class="company"></div>
                    </div>
                    <!--//meta-->
                    <div class="details">
	              <p> • One-year joint education of B. Med as <strong> Outstanding Student in Fudan University</strong>, China (2020 QS world university
                    Ranking: 40)</p>
                       <p> • <strong>Bachelor’s degree of Medicine, Chongqing Medical University, China;</strong> (Major: Clinical medicine, which is listed in the
                        Top 1% of the global ESI ranking)</p>
                        <p>• <strong>Curriculum:</strong> Basic medical courses and clinical practice</p>
                        
                    <p>  • <strong>GPA:</strong> 3.43 （26th out of the 139 students in our department）</p>

                
                    </div>
                    <!--//details-->
                </div>
                <!--//item-->





                <div class="item">
                    <div class="meta">
                        <div class="upper-row">
                            <h3 class="job-title">M. Med</h3>
                            <div class="time">Sept. 2018-June. 2021</div>
                        </div>
                        <!--//upper-row-->
                        <div class="company"></div>
                    </div>
                    <!--//meta-->
                    <div class="details">
                
                    
                <p> • <strong>Master's degree of Medicine, Chongqing Medical University, China</strong></p>
			    
		
               
                <p>  • <strong>Thesis:</strong> Researches and medical popularization about breast, thyroid and parathyroid diseases, which mainly focused on exploring breast and thyroid tumor etiologies, epidemiology, screening strategy, and hepatitis B virus related extrahepatic cancers</p>
                <p> • <strong>Achievement:</strong> Published <strong>18 works (including 7 first-author SCI papers) on high-quality journals of JAMA, the
                    Lancet, Journal of hepatology, Thyroid,</strong> ect; Participated in the editing and publishing of 5 books about thyroid and
                    breast health</p>
                <p>  • <strong>Advisor:</strong> Prof. Lingquan Kong (ORCID: 0000-0001-5705-9001)</p>

                
                    </div>
                    <!--//details-->
                </div>
                <!--//item-->



               
                
            </section><!--//section-->
            
            <section class="section projects-section">
                <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>EXPERIENCE</h2>
                <div class="intro">
            
                    <h3 class="job-title" style="margin-bottom: 20px;">Experimental Research</h3>
        <p> <strong>  Project 1</strong>: Effects of different physiological levels of estradiol on the chemosensitivity of HR+ breast cancer</p>
        <p> • <strong>Aim:</strong> To explore the effects of different physiological levels of estradiol (E2) on the chemosensitivity of breast
            cancer to epirubicin (EPI).</p>
        <p> •<strong> Methods:</strong> CCK-8 assay was used to observe the proliferation of MCF-7 and MDA-MB-231 cells treated with E2 (0, 50, 500,
            2500, 5000, 10000pg/ml) for 24h．After pretreatment with different doses of E2 for 12h and then treated with EPI alone
            for 24h, the effects of E2 on the chemosensitivity of MCF-7 and MDA-MB-231 cells to EPI were detected by CCK-8 assay.
            MCF-7 tumor-bearing nude mice were randomly assigned to Non-OVX+EPI group (group B), OVX+EPI group (group D), OVX+E2+EPI
            group (group E, F and G) and control group. After being treated with EPI, tumor inhibition rates were calculated to
            detect the effects of E2 on tumor inhibition of EPI chemotherapy.</p>
        <p>  •<strong>Conclusion:</strong> E2 dose-dependently promoted the chemosensitivity of MCF-7 cells to EPI, suggested that applied the
            chemotherapy in physiological periods with higher E2 level might improve the chemotherapy efficacy in HR+ breast cancer.</p>
        <p> •<strong> Major Responsibility: </strong>1. Retrieve and review relevant literatures 2. Participate in experimental design and
            responsible for the operation of some experiments, such as cell culture, tumors-bearing of naked mice, surgery of
            animals etc. 3. Data analysis and statistical graphs drawing 4. Discussion of the results and conclusion.</p>
        <p> • <strong>Published paper of this project:</strong> Jia-shuo Liu, Zhou Xu, Ling-quan Kong, Baoshan Zou,  <strong>Hao Li,</strong> Kai-nan Wu. Effects of
            different physiological levels of estradiol on the chemosensitivity of HR+ breast cancer. 16th Chinese Breast Cancer
            conference. 15th Shanghai International Breast Cancer Symposium. 2020: E002.</p>
	<p> -                                        </p>
            
        <p>  <strong>Project 2:</strong> Effect of dexamethasone during chemotherapy of breast cancer</p>
        <p>  • <strong>Aim: </strong>To investigate the effect of dexamethasone (DEX) on the anticancer activity of anthracycline chemotherapy in
            routine TAC chemotherapy regimen of breast cancer.</p>
        <p> • <strong>Methods:</strong> The effects of different concentrations of dexamethasone combined with doxorubicin on the viability of breast
            cancer cells were detected by CCK-8. Flow cytometry was used to detect the effect of dexamethasone and doxorubicin on
            breast cancer cells apoptosis rate; real-time quantitative PCR and western blot were used to detect the effects of
            different concentrations of dexamethasone and doxorubicin on the expression of bcl-2 family related genes and protein.</p>
        <p> • <strong>Conclusion:</strong>The conventional dexamethasone dosage in TAC chemotherapy regimen may reduce the effect of doxorubicin
            chemotherapy by inhibiting the apoptosis pathway of bcl-2, promote the proliferation activity of breast cancer cells in
            vitro and inhibit the apoptosis of cells. Therefore, TAC chemotherapy should be avoided using dexamethasone.</p>
        <p>  •<strong> Major Responsibility: </strong>1. Retrieve and review relevant literatures 2. Responsible for the operation of some
            experiments, such as cell culture, western blot, flow cytometry and Hoechst staining etc. 3. Discussion of the results
            and conclusion.</p>

                  
                    <!-- <p>You can list your side projects or open source libraries in this section. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum et ligula in nunc bibendum fringilla a eu lectus.</p> -->
                </div>
                <!--//intro-->
                <!-- <div class="item">
                                <span class="project-title"><a href="https://themes.3rdwavemedia.com/bootstrap-templates/startup/coderpro-bootstrap-4-startup-template-for-software-projects/" target="_blank">CoderPro</a></span> - <span class="project-tagline">A responsive website template designed to help developers launch their software projects. </span>
                                
                            </div> -->
            
                <!--//item-->
            
            </section>
            <!--//section-->


<section class="section projects-section">
    <!-- <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>EXPERIENCE</h2> -->
    <div class="intro">
	    
	   <h3 class="job-title" style="margin-bottom: 20px;">Clinical Research</h3>

                   <p> • <strong>I have been analyzing cancer related clinical data by using local medical database of hospitals and health-care
                    centers, and public medical database from internet (SEER, GEO, TCGA ect.), especially focusing on the epidemiology and
                    screening strategy of breast cancer and thyroid cancer in Chinese population.</strong> Besides, I have been collecting clinical
                    data and trying to analyze the relationship between breast cancer and other diseases, such as thyroid diseases, liver
                    diseases (viral hepatitis, drug-induced liver injury, metabolic related fatty liver disease), diabetes mellitus,
                    cardiovascular diseases etc. And I have mastered statistics analysis and data-mining with R or SAS projects.</p>
                <p> • <strong>Currently, I have published 18 papers, of which 14 were SCI (Science Citation Index) papers (including 7 fist-author
                    SCI papers).</strong> One of my first-author original article was published on <strong>Thyroid (IF 7.8)</strong>, which currently is the top one
                    journal in the area of thyroid diseases. And another co-first author Letter with original data was published on the
                    <strong>Journal of Hepatology (IF18.9)</strong>. I also have participated in the editing and publishing of five books about thyroid and
                    breast health, including “Breast oncological endocrinology and metabolism”, “Breast Oncocardiology”, “Concomitant
                    Disease of Breast Cancer”, “Fundamentals of Surgical Operation”, “Caring for Parathyroid Health”.</p>
                <p> • Additionally, I have a certain ability of critical thinking and logical thinking, and I have published three comment
                    papers (as first author) in prestigious journals, including <strong>JAMA (IF 51.3), Diabetes Care (IF 15.3) and Diabetologia (IF
                    7.1)</strong>, in which I pinpointed their design defects in original studies and provide corresponding solutions.</p>
                    <!-- <p>You can list your side projects or open source libraries in this section. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum et ligula in nunc bibendum fringilla a eu lectus.</p> -->
                </div><!--//intro-->
                <!-- <div class="item">
                    <span class="project-title"><a href="https://themes.3rdwavemedia.com/bootstrap-templates/startup/coderpro-bootstrap-4-startup-template-for-software-projects/" target="_blank">CoderPro</a></span> - <span class="project-tagline">A responsive website template designed to help developers launch their software projects. </span>
                    
                </div> -->
                
                <!--//item-->
               
            </section><!--//section-->




            <section class="section projects-section">
                <!-- <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>EXPERIENCE</h2> -->
                <div class="intro">

        <h3 class="job-title" style="margin-bottom: 20px;">Clinical experience</h3>
        <p> <strong>• Sept.2017-June.2018:</strong>  I received one-year systematic internship at the First Affiliated Hospital of Chongqing Medical
        University and mastered the basic skills of diagnosis and treatment of common diseases. Long-term training of medical
        history collecting and recording and case discussions enabled me to improve my capability of writing, organizing words,
        expressing and diagnosis. And above all, I learned how to deal with various interpersonal relationships, especially with
        patients.
        </p>
        <p> <strong>• Sept.2018-present:</strong> I received national standardized training for resident doctors at the First Affiliated Hospital of
        Chongqing Medical University, working as a resident in all surgical departments in order. During the training, I have
        been familiar with diagnosis and treatment of common surgical diseases. In addition, I participated in a large number of
        surgeries and professional academic conferences, which enlightened me with several scientific ideas for further
        researches. I also grasped the basic methods of medical literature retrieval, data mining and analysis as well as
        medical paper writing, and had good ability of scientific research.</p>
       
        <!-- <p>You can list your side projects or open source libraries in this section. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum et ligula in nunc bibendum fringilla a eu lectus.</p> -->
    </div>
    <!--//intro-->
    <!-- <div class="item">
                    <span class="project-title"><a href="https://themes.3rdwavemedia.com/bootstrap-templates/startup/coderpro-bootstrap-4-startup-template-for-software-projects/" target="_blank">CoderPro</a></span> - <span class="project-tagline">A responsive website template designed to help developers launch their software projects. </span>
                    
                </div> -->

    <!--//item-->

</section>
<!--//section-->








<section class="section projects-section">
    <h2 class="section-title"><span class="icon-holder"><i class="fas fa-market"></i></span>PUBLICATIONS--PAPERS</h2>
    <div class="intro">

        <h3 class="job-title" style="margin-bottom: 20px;">* below indicates equal contribution</h3>

    <p> <strong>1. Hao Li,</strong> Ze Wang, Jia-shuo Liu, Bao-shan Zou, et al. Association between breast and thyroid lesions: a cross-sectional study based on
        ultrasonography screening in China. Thyroid. 8 Mar 2020. <a href="https://doi.org/10.1089/thy.2019.0184" style="color: blue;">(https://doi.org/10.1089/thy.2019.0184)</a></p>
  
    <p> <strong>2. Hao Li,</strong> Zhou Xu, Shen Tian, Ling-quan Kong. High-Dose Vitamin D Supplementation and Bone Health. JAMA. January 7,
        2020 Volume 323, Number 1. <a href="https://doi.org/10.1001/jama.2019.18147" style="color: blue;">( https://doi.org/10.1001/jama.2019.18147)</a></p>
    
    <p> <strong>3. Hao Li,</strong> Liang Ran, He Wu, et al. A population-based study of the relationship between
        endometrial thickness and prevalence of breast mass in postmenopausal women. Int J Gynaecol Obstet. 2019 Mar 30.
        <a href="https://doi.org/10.1002/ijgo.12814" style="color: blue;">(https://doi.org/10.1002/ijgo.12814)</a></p>
  
    <p> <strong>4. Hao Li,</strong> Shen Tian, Ling-quan Kong. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases,
        Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care. 2019;42:1504–151. Diabetes
        Care 2020;43:e8. <a href="https://doi.org/10.2337/dc19-1802" style="color: blue;"> (https://doi.org/10.2337/dc19-1802)</a></p>
	
    <p>  <strong>5. Hao Li,</strong> Shen Tian, Juan Wu, Zhou Xu, Ling-quan Kong. Diagnostic criteria should be considered when reviewing the
        effect of diabetes prevention studies. Diabetologia. <a href="https://doi.org/10.1007/s00125-019-05000-x" style="color: blue;">(https://doi.org/10.1007/s00125-019-05000-x)</a></p>
	  
    <p> <strong>6.</strong> Zhou Xu*, <strong>Hao Li*,</strong> Shen Tian*, et al. On the blood biomarker for the diagnosis of metabolic associated fatty liver disease.
        Journal of Hepatology. <a href="https://doi.org/10.1016/j.jhep.2020.06.003" style="color: blue;"> (https://doi.org/10.1016/j.jhep.2020.06.003)</a> </p> 
	    <p>                                         </p>
    <p> <strong>7.</strong> Yanling Shi*, Xin Li*, Liang Ran*, Bilal Arshad*, <strong>Hao Li*,</strong> et al. Study on the status of thyroid function and thyroid nodules in chinese breast
        cancer patients. Oncotarget. 2017 Aug 24;8:80820-80825. 
	    <p>                                        </p>
    <p> <strong>8. Hao Li,</strong> Huan Luo, Ling-quan Kong,et al. Strengthening the comprehensive management of concomitant
        diseases of breast cancer: endocrine and metabolic diseases. Chinese Journal of New Clinical Medicine. February 2019.
        Volume 12, Number 2. <a href="http://doi.org/10.3969/j.issn.1674-3806.2019.02.01" style="color: blue;">(http://doi.org/10.3969/j.issn.1674-3806.2019.02.01)</a></p>
	    <p>                                         </p>
    <p> <strong>9. Hao Li,</strong> Ling-quan Kong, Kai-nan Wu. Establishment of breast oncocardiology and significance of multidisciplinary
        collaboration on treatment of breast cancer. Chinese Journal of New Clinical Medicine, 2018,11(1):94-97.
        <a href="http://doi.org/10.3969/j.issn.1674-3806.2018.01.28" style="color: blue;">(http://doi.org/10.3969/j.issn.1674-3806.2018.01.28)</a></p>
	    <p>                                         </p>
    <p> <strong>10. Hao Li,</strong> Ya-ying Yang, Ling-quan Kong, et al. One case of flat epithelial atypia
        revealed by mammotome biopsy and finally confirmed to be complicated by breast spindle cell carcinoma. Journal of
        Endocrine Surgery, 2017,11(5)430-431.<a href="http://doi.org/10.3760/cma.j.issn.1674-6090.2017.05.021" style="color: blue;"> (http://doi.org/10.3760/cma.j.issn.1674-6090.2017.05.021)</a></p>
	<p>                                         </p>
    <p> <strong>11.</strong> Zhou Xu, Shu Li, Shen Tian, <strong>Hao Li,</strong> Ling-quan Kong. Full spectrum of COVID-19 severity still being depicted. Lancet.
        February 14, 2020. <a href="https://doi.org/10.1016/S0140-6736(20)30308-1" style="color: blue;">(https://doi.org/10.1016/S0140-6736(20)30308-1)</a></p>
	<p>                                         </p>
    <p> <strong>12.</strong> Zhou Xu, Feng Luo, Y Wang, Bao-shan Zou, Yuan Man, Jia-shuo Liu, <strong>Hao Li,</strong> et al. Cognitive impairments in breast cancer survivors treated with chemotherapy: a
        study based on event-related potentials. Cancer Chemother Pharmacol 85, 61–67 (2020).
        <a href="https://doi.org/10.1007/s00280-019-03994-0" style="color: blue;">(https://doi.org/10.1007/s00280-019-03994-0)</a></p>
	<p>                                         </p>
    <p> <strong>13.</strong> Tian S, <strong>Hao Li,</strong> Juan Wu, et al. Lifestyle intervention and impaired glucose tolerance in the Da
        Qing study. Lancet Diabetes Endocrinol 2019;7:669-670. <a href="https://doi.org/10.1016/S2213-8587(19)30261-X" style="color: blue;">(https://doi.org/10.1016/S2213-8587(19)30261-X)</a></p>
	<p>                                         </p>
    <p> <strong>14.</strong> Juan Wu, Rong Kong, Shen Tian, <strong>Hao Li,</strong> et al. Can trastuzumab emtansine be replaced by
        additional chemotherapy plus targeted therapy for HER2-overexpressing breast cancer patients with residual disease after
        neoadjuvant chemotherapy? Chin J Cancer Res 2019;31(6):878-891. <a href="http://doi.org/10.21147/j.issn.1000-9604.2019.06.04" style="color: blue;">(http://doi.org/10.21147/j.issn.1000-9604.2019.06.04)</a></p>
	<p>                                         </p>
    <p> <strong>15.</strong> Xin Li, Zi-li Liu, Yu-tuan Wu, He Wu, Wei Dai, Bilal Arshad, Zhou Xu, <strong>Hao Li,</strong> et al. Status of
        lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy. Lipids in Health
        and Disease 2018;17:91. <a href="http://doi.org/10.1186/s12944-018-0745-1" style="color: blue;">(http://doi.org/10.1186/s12944-018-0745-1)</a></p>
	<p>                                         </p>
    <p> <strong>16.</strong> Yu-tuan Wu, Qing-qing Luo, Xin Li, Bilal Arshad, Zhou Xu, Liang Ran, Chun-xia Zhao, He Wu, Yan-ling Shi, Hao-ran
        Chen, <strong>Hao Li,</strong> et al. Clinical study on the prevalence and comparative analysis of
        metabolic syndrome and its components among Chinese breast cancer women and control population. Journal of Cancer
        2018;9(3):548-555. <a href="http://doi.org/10.7150/jca.22968" style="color: blue;">(http://doi.org/10.7150/jca.22968)</a></p>
	<p>                                         </p>
    <p> <strong>17.</strong> Yu-tuan Wu, Zhou Xu, Bilal Arshad, Jiu-song Wu, Ke Zhang, He Wu, Xin Li, <strong>Hao Li,</strong> et al. Significantly higher pathologic complete response (pCR) after the concurrent use of
        trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a
        meta-analysis of randomized controlled trials. Journal of Cancer, 2018; 9(17): 3168-3176.
        <a href="http://doi.org/10.7150/jca.24701" style="color: blue;">(http://doi.org/10.7150/jca.24701)</a></p>
    <p> <strong>18.</strong> Jia-shuo Liu, Zhou Xu, Ling-quan Kong, Baoshan Zou, <strong>Hao Li,</strong> Kai-nan Wu. Effects of different physiological levels of estradiol on the chemosensitivity of HR+ breast cancer. 16th Chinese Breast Cancer conference. 15th Shanghai International Breast Cancer Symposium. 2020: E002.</p>
    
    </div>

</section>




<section class="section projects-section">
    <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>PUBLICATIONS--BOOKS</h2>
    <div class="intro">

        <!-- <h3 class="job-title" style="margin-bottom: 20px;">* below indicates equal contribution</h3> -->
       
<p>  1. Lingquan Kong, Kainan Wu, et al. Breast oncological endocrinology and metabolism, Beijing: Science Press, China, 2020
(English edition) (In press)</p>
<p>2. Lingquan Kong, Kainan Wu, Hongyuan Li et al. Breast Oncocardiology, Beijing: Science Press, China, 2018</p>
<p>3. Lingquan Kong, Kainan Wu, Lei Guo et al. Concomitant Disease of Breast Cancer, Beijing: Science Press, China, 2018</p>
<p>4. Kainan Wu, Lingquan Kong, Zhou Xu et al. Fundamentals of Surgical Operation, 2rd ed; Beijing: People's Medical
Publishing House (PMPH), 2018</p>
<p>5. Lingquan Kong, Kainan Wu et al. Caring for Parathyroid Health, Beijing: Science Press, China. (In press)</p>


<h3 class="job-title" style="margin-bottom: 20px;">Clinical trails</h3>

<p>ChiCTR1800015681: The relationship between breast disease and thyroid disease: an ultrasound-based cross-sectional
study. (As principal)</p>


    </div>

</section>




<section class="section projects-section">
    <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>AWARDS & CERTIFICATES</h2>
    <div class="intro">

        <!-- <h3 class="job-title" style="margin-bottom: 20px;">* below indicates equal contribution</h3> -->

        <p>•<strong>2013-2014 </strong> Outstanding Cadres of the Red Cross Society of Fudan University;</p>
        <p>• <strong>2014 </strong> Certificate of National Higher College Computer Rank Test (Chongqing District) for Non-Computer Major Students</p>
        <p> • <strong>2014 </strong> Certificate of National Computer Rank Examination (level 2)</p>
        <p> •<strong>2015-2016 </strong> Outstanding Cadres of Faculty of Chongqing Medical University</p>
        <p> • <strong>2019 </strong> National Scholarship</p>
        <p> • <strong>2019 </strong> Award of outstanding youth in Chongqing</p>
    <p>  • <strong>2019 </strong> Doctor Qualification Certificate</strong></p>



    </div>

</section>

 <section class="section summary-section">
                <h2 class="section-title"><span class="icon-holder"><i class="fas fa-user"></i></span>RESEARCH SKILLS</h2>
                <div class="summary">


<h3 class="job-title" style="margin-bottom: 1rem;">Languages</h3>
<p>• Proficient in English writing and speaking</p>
<p>• Mandarin: Mother tongue</p>
<p>• R project</p>
			
<h3 class="job-title" style="margin-bottom: 1rem;">Laboratory skills</h3>
<p>• Proficient in techniques of cell culture, frozen section, western blotting, ELISA, migration assay, matrigel invasion
assay, TUNEL Experiment, flow cytometry, immunofluorescence, Tumor-bearing of mice, Surgery of animals.</p>
<p>• Familiar with common molecular biology technology, including plasmid preparation, DNA, RNA and protein extraction and
purification, PCR, RFLP, and probe design.</p>			

<h3 class="job-title" style="margin-bottom: 1rem;">Clinical research skills</h3>
<p>• Proficient in medical data-mining and using several public medical database, including SEER database, MIMIC database,
GEO database, TCGA database and some local medical database et, al.</p>
<p>• Proficient in data analysis by using R project / SAS / STATA / SPSS software</p>

            
                </div>
                <!--//summary-->
            </section>
            <!--//section-->



<section class="section projects-section">
    <h2 class="section-title"><span class="icon-holder"><i class="fas fa-archive"></i></span>ABOUT ME</h2>
    <div class="intro">

        <!-- <h3 class="job-title" style="margin-bottom: 20px;">* below indicates equal contribution</h3> -->

    <p>• Excellent learning capacity and logical thinking</p>
    <p> • Strong problem-solving skills and a capacity to produce results</p>
    <p> • A curious and creative mind combined with excellent analytical skills</p>
    <p> • Ability to work independently and in collaboration with others</p>



    </div>

</section>

            
           
            
        </div><!--//main-body-->
    </div>
 
    <footer class="footer">
        <div class="text-center">
            <!--/* This template is free as long as you keep the footer attribution link. If you'd like to use the template without the attribution link, you can buy the commercial license via our website: themes.3rdwavemedia.com Thank you for your support. :) */-->
            <!-- <small class="copyright">Designed with <i class="fas fa-heart"></i> by <a href="http://themes.3rdwavemedia.com" target="_blank">Xiaoying Riley</a> for developers</small> -->
        </div><!--//container-->
    </footer><!--//footer-->
    
    <!-- *****CONFIGURE STYLE (DEMO ONLY)****** -->  
   
    
    <!-- DEMO ONLY -->
    <script type="text/javascript" src="demo/jquery-3.4.1.min.js"></script>
    <script type="text/javascript" src="demo/demo.js"></script>  
        
</body>
</html> 

